Crestline Investors — 2013 Investments

1 investments dated 2013 · listed companies and verified rows first · show all

Juno Therapeuticsjunotherapeutics.comDec 2013Acquired

Seattle-based cancer immunotherapy company developing CAR-T and TCR cell therapies; acquired by Celgene, now part of Bristol-Myers Squibb.

BiotechSeattle, US

Hans Bishop(Executive Officer, Director, Promoter)Richard Klausner(Director, Promoter)Bernard J. Cassidy(Executive Officer)Robert Azelby(Executive Officer)Sunil Agarwal(Executive Officer)Rupert Vessey(Director)

Co-investorsARCH Venture Partners Bezos Expeditions Ridgeback Capital Alaska Permanent Fund Corporation Venrock

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.